clemastine

(redirected from Tavist-d)

clemastine

 [klem´as-tēn]
an antihistamine with sedative and anticholinergic effects; used as the fumarate salt in the treatment of nasal, eye, and skin manifestations of allergic reactions, including allergic rhinitis, conjunctivitis, and itching, and also as an ingredient in cough and cold preparations, administered orally.

clemastine

/clem·as·tine/ (klem´as-tēn) an antihistamine with anticholinergic and sedative effects, used as the fumarate salt.

clemastine

[klemas′tēn]
an antihistamine.
indications It is prescribed in the treatment of symptoms of allergic rhinitis, pruritus, or conjunctivitis.
contraindications Use by lactating mothers or those undergoing monamine oxidase inhibitor therapy or having known sensitivity to this drug or other antihistamines is contraindicated. It is also contraindicated with narrow-angle glaucoma, asthma, symptomatic prostatic hypertrophy, and bladder-neck destruction.
adverse effects Among the most serious adverse reactions are hypersensitivity, skin rash, and tachycardia. Transient drowsiness commonly occurs.

clemastine

A sedating antihistamine and anticholinergic used for managing allergic rhinitis and hay fever.

Adverse effects
CNS depression or stimulation; the latter is more common in children and may be accompanied by excitement, hallucinations, ataxia, incoordination, spasms, athetosis, hyperthermia, cyanosis, hyperreflexia and cardiorespiratory arrest.

clemastine

An ANTIHISTAMINE drug used to treat hay fever and other allergic conditions. A brand name is Tavegil.
References in periodicals archive ?
Novartis Consumer Health is also currently awaiting FDA approval of PPA-free Tavist Allergy Sinus Headache, which will provide the decongestant benefits of Tavist-D plus pain relief with pseudoephedrine as the decongestant ingredient.
The case is one of the first class actions filed against the defendants over the use of phenylpropanolamine (PPA) in such common over-the-counter products as Alka-Seltzer, Comtrex, Tylenol, Tavist-D, Triaminic, Contac, Halls Mentho-Lyptus, Sinutab, Robitussin and Dexatrim.
Tavist-1 and Tavist-D, which were introduced as over-the-counter medications in full prescription strength in 1992, have long been used by millions of Americans for relief from sinus and allergy symptoms.
Sandoz also said it would continue full marketing support for Tavist-D under the product's brand name.
The conversion of the Tavist-D brand from prescription to OTC status in 1992 represents one of the most successful switches in the industry and our future efforts will be directed at maintaining Tavist-D as the leader in the marketplace," said Robert G.
Perrigo Chairman and CEO Mike Jandernoa noted, "We are very pleased to enter into this arrangement with Sandoz in our effort to be the first store brand marketer of a product comparable to Tavist-D.
Currently, the only major brand which contains the ingredient clemastine fumarate is Tavist-D and Tavist-1.
Tavist-1 and Tavist-D, which were introduced as over-the-counter medications in 1992 after years of prescription use, have long been used by millions of Americans for relief from sinus and allergy symptoms.
Products such as TheraFlu, Tavist-D and the Triaminic line of children's cough and cold products have established Sandoz as a leader in significant segments of the over-the-counter marketplace," said Pulido.
Sandoz markets such popular over-the-counter drugs as the decongestants, Tavist-D and Tavist-1 and TheraFlu for flu symptoms.